BREAKING THROUGH FOR BETTER PATIENT CARE 

BREAKING THROUGH FOR BETTER PATIENT CARE 

NCODA partners with Prime Therapeutics to offer accreditation for its new MIP program    Since 2016, “Going Beyond the First Fill” has been NCODA’s credo and the primary focus of its Mission to create a patient-centered, safe, high-quality, comprehensive program to...
THE UNDERLYING BIAS OF PHARMACOGENOMICS 

THE UNDERLYING BIAS OF PHARMACOGENOMICS 

RACIAL EXCLUSION IN CANCER CLINICAL TRIALS HAS LEFT BEHIND THE POPULATIONS MOST IN NEED OF TREATMENT  By Porscha Johnson, PharmD, CPGx  While research has led to profound advancements in cancer treatments — including antibody-drug conjugates and immunotherapy, as well...